Understanding drug testing in the neonate and the role of meconium analysis

Journal of Perinatal and Neonatal Nursing

Volumn 14, Issue 4, 2001, Pages 61-82

  Ostrea Jr , Enrique M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug dependent; Infant of drug dependent mother; Meconium; Neonatal drug testing; Pregnant addict

Indexed keywords

ARTICLE; CHEMISTRY; FEMALE; HUMAN; MECONIUM; METHODOLOGY; NEWBORN; NEWBORN SCREENING; PREGNANCY; SUBSTANCE ABUSE;

FEMALE; HUMANS; INFANT, NEWBORN; MECONIUM; NEONATAL SCREENING; PREGNANCY; SUBSTANCE ABUSE DETECTION;

EID: 0035295806     PISSN: 08932190     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005237-200103000-00006     Document Type: Article

References (86)

1. Substance Abuse and Mental Health Services Administration. Household Survey on Drug Abuse: Main Findings 1995. DHHS Publication Number (SMA)95-3127, Washington DC: US Government Printing Office; 1997.
2. Chasnoff IJ. Drug use and women. Establishing a standard of care. Ann NY Acad Sc. 1989;562:208-210.
3. Ostrea EM, Brady M, Cause S, et al. Drug screening of newborns by meconium analysis: A large scale, prospective, epidemiologic study. Pediatr. 1992;89:107.
4. Ostrea EM, Chavez CS. Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: A study of 830 cases. J Pediatr. 1979;94:292.
5. Chasnoff IJ, Burns WE, Schnoll SH, et al. Cocaine use in pregnancy. New Engl J Med. 1985;313:666.
6. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. J Pediatr. 1987; 111:571.
7. MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy. Adverse perinatal outcome. Am J Obstet Gynecol. 1987;157:686.
8. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. New Engl J Med. 1989; 320:762.
9. Zelson C, Rubio E, Wasserman E. Neonatal narcotic addiction. 10 year observation. J Pediatr. 1971;48:178.
10. Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: Effects on the fetus and newborn. Neurotoxicol Teratol. 1987; 9:295.
11. Fulroth R, Phillips B, Durand D. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Amer J Dis Child. 1989;143:905.
12. Chasnoff IJ, Bussy ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr. 1986;108:456.
13. Chasnoff IJ, Hunt CE, Kletter R, Kaplan D. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am J Dis Child. 1989;143:583.
14. Ostrea EM, Jr, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976;88:642.
15. Ostrea EM, Jr, Kresbach P, Knapp DK, Simkowski K. Abnormal heart rate tracings and serum creatine phosphokinase in addicted neonates. Neurotoxicol Teratol. 1987;9:305.
16. Oleske J, Minnefor A, Cooper R, et al. Immune deficiency syndrome in children. JAMA. 1983;249:2345.
17. Wilson GS, McCreary R, Kean J, Baxter J. The development of preschool children of heroin addicted mothers: A controlled study. Pediatrics. 1979;63:135.
18. Chavez CJ, Ostrea EM, Stryker JC, Smialek T. Sudden infant death syndrome among infants of drug dependent mothers. J Pediatr. 1979;95:407.
19. Chasnoff IJ, Hatcher R, Burns WE. Polydrug and methadone addicted newborns. A continuum of impairment. Pediatrics. 1982;70:210.
20. Chavez CJ, Ostrea EM, Stryker JC, Strauss ME. Ocular abnormalities in infants as sequelae of prenatal drug addiction. Pediatr Res. 1979;12:367A.
21. Wilson GS. Clinical studies of infants and children exposed prenatally to heroin. Ann NY Acad Sci. 1989;562:183.
22. Kandall SR, Gartner LM. Late presentation of drug withdrawal symptoms in newborns. Am J Dis Child. 1974;127:58.
23. Khavari K, Farber P. A profile instrument for the quantification and assessment of alcohol consumption. J Stud Alcohol. 1978;39:1525.
24. Khavari KA, Douglas FM. The drug use profile (DUP): An instrument for clinical and research evaluations for drug use patterns. Drug Alcohol Depend. 1981;8:119.
25. Cahalan D, Cisin I, Crossley H. American drinking practices. Monograph No. 6. New Brunswick, NJ: Rutgers Center of Alcohol Studies; 1969.
26. Bracken MB, Leaderer B, Belanger K. Role of biologic markers in epidemiologic studies of prenatal drug exposure: Issues in study design. In: M.M. Kilbey, K. Asghar, eds. Methodological Issues in Epidemiological, Prevention and Treatment Research on Drug Exposed Women and Their Children. (Monograph 117). Rockville, MD: National Institute on Drug Abuse. DHHS Publication. No. 92-1881, 1992;96.
27. Ostrea EM, Morales V, Ngoumgna E. Use of biological markers in assessing drug abuse. A review of the literature. NIDA Resource Center for Health Services Research. Contract No. N01DA-5-6050 (in press).
28. Brogan WC, Kemp PM, Bost RO, Glamann DB, Lange RA, Hillis LD. Collection and handling of clinical blood samples to assure the accurate measurement of cocaine concentration. J Anal Toxicol. 1992; 16:152-154.
29. Baselt R, Shaw R, McEvillly R. Effect of sodium fluoride on cholinesterase activity in postmortem blood. J Foren Sci. 1985;30:1206-1209.
30. Schonberg SK, ed. Substance Abuse: A Guide for Health Professionals. Elk Grove, IL: American Academy of Pediatrics and Center for Advanced Health Studies, 1988; 48-66.
31. Halstead AC, Godolphin W, Lockitch G, Segal S. Timing of specimen collection is crucial in urine screening of drug-dependent mothers and newborns. Clin Biochem. 1988;21:59-61.
32. Ostrea EM, Brady MJ, Parks PM, Asensio DC, Naluz A: Drug screening of meconium in infants of drug dependent mothers. An alternative to urine screening. J Pediatr. 1989;115:474-477.
33. Osterloh JD, Lee BL. Urine drug screening in mothers and infants. Amer J Dis Child. 1989;43:791-793.
34. Baumgartner WA, Hill VA, Blahd W. Hair analysis for drugs of abuse. J Foren Sci. 1989;34:1433-1453.
35. Springfield AC, Cartmell LW, Aufderheide AC, Buikstra J, Ho J. Cocaine and metabolites in the hair of ancient Peruvian coca leaf chewers. Foren Sci Internat. 1993; 63:269-275.
36. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA. 1989;262:3328-3333.
37. Klein J, Forman R, Eliopoulos C, Koren G. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Therap Drug Monit. 1994;16:67-70.
38. Baumgartner WA, Hill VA. Sample preparation techniques. Forens Sci Internat. 1993;63:121-135.
39. Cone EJ, Yousefnejad D, Darwin WD, Maguire T. Testing human hair for drugs of abuse. II. Identification of unique cocaine metabolites in hair of drug abusers and evaluation of decontamination procedures. J Anal Toxicol. 1991;15(5):250-255.
40. Welch MJ, Sniegoski LT, Allgood CC, Habram M. Hair analysis for drugs of abuse: evaluation of analytical methods, environmental issues, and development of reference materials. J Anal Toxicol. 1993; 17:389-398.
41. Cone EJ, Darwin WD, Wang WL. The occurrence of cocaine, heroin and metabolites in hair of drug abusers. Forens Sci Internat. 1993;63:55-68.
42. Ripple MG, Goldberger BA, Caplan YH, Blitzer MG, Schwartz S. Detection of cocaine and its metabolites in human amniotic fluid. J Anal Toxicol. 1992;16:328-331.
43. Casanova OQ, Lombardero N, Behnke M, Eyler FD, Conlon M, Bertholf RL. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch Path Lab Med. 1994;118:988-993.
44. Mahone PR, Scott K, Sleggs G, D'Antoni T, Woods JR Jr. Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Amer J Obstet Gynecol. 1994;171: 465-469.
45. Jain L, Meyer W, Moore C, Tebbett I, Gauthier D, Vidyasagar D. Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet Gynecol. 1993;81:787-790.
46. O'Connor TA, Ringer KM, Kilbride HW. Cocaine detection in neonatal gastric aspirate samples. J Perinat. 1996;16:197-198.
47. Garcia D, Romero A, Garcia G, Ostrea EM. Gastric fluid analysis for determining gestational cocaine exposure. J Pediatr. 1996; 98:291-293.
48. Ostrea EM, Lynn SN, Wayne RH, Stryker JC. Tissue distribution of morphine in the newborns of addicted monkeys and humans. Dev Pharmacol Ther. 1980;1:163.
49. Ostrea EM, Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug dependent mothers. An alternative to urine screening. J Pediatr. 1989;115:474-477.
50. Silvestre MA, Lucena JE, Roxas R, Evangelista E, Ostrea EM. The effect of timing, dosage and duration of morphine intake during pregnancy on the amount of morphine in meconium in a rat model. Biol Neonate. 1997;72:112-117.
51. Ostrea EM, Parks P, Brady M. Rapid isolation and detection of drugs in meconium of infants of drug dependent mothers. Clin Chem. 1988;34:2372-2373.
52. Ostrea EM, Romeo A, Yee H. Adaptation of the meconium drug test for mass screening. J Pediatr. 1993;122:152.
53. Winger WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J Forens Sci. 1994, 39(1):150-158.
54. Mac E, Matias O, Ostrea EM, Mazhar M. Clinical adaptation of HPLC to meconium drug testing. Pediatr Res. 1995;37:221A.
55. Murphey LJ, Olsen GD, Konkol RJ. Quantitation of benzoyl norecgonine and other cocaine metabolites in meconium by high-performance liquid chromatography. J Chromatogr. 1993;613(2):330-335.
56. Browne SP, Tebbett IR, Moore CM, Dusick A, Covert R, Yee GT. Analysis of meconium for cocaine in neonates. J Chromatogr. 1992;75(1):158-161.
57. Callahan CM, Grant TM, Phipps BS, Clark G, Novack AH, Streissguth AP, Raisys VA. Measurement of gestational cocaine exposure: Sensitivity of newborn hair, meconium and urine. J Pediatr. 1992;120:763.
58. Montes N, Romero A, Ostrea EM, Ostrea MR. Improved method of GC/MS analysis of meconium for opiate, cocaine and cannabinoid. Pediatr Res. 1993;33:66A.
59. Oyler J, Darwin WD, Prestoin KL, Suess P, Cone EJ. Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users. J Anal Toxicol. 1996;20:453-462.
60. Moore C, Lewis D, Leikin J. False positive and false-negative rates in meconium drug testing. Clin Chem. 1995;41:1614-1616.
61. Clark GD, Rosenweig B, Raisys VA, Callahan CM, Grant TM, Streissguth AP. The analysis of cocaine and benzoylecgonine in meconium. J Anal Toxicol. 1992;16:261-263.
62. Lombardero N, Casanova O, Behnke M, Eyler FD, Bertholf RL. Measurement of cocaine and metabolites in urine, meconium and diapers by gas chromatography/ mass spectrometry. Ann Can Lab Sci. 1993; 23:385-394.
63. Moore C, Lewis D, Becker J, Leikin J. The determination of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) in meconium. J Anal Toxicol. 1996;20(1):50-51.
64. Moore CM, Deitermann D, Lewis D, Leikin J. The detection of hydrocodone in meconium: two case studies. J Anal Toxicol. 1995;19(6):514-518.
65. Steele BW, Bandstra ES, Wu NC, Hime GW, Hearn WL. m-Hydroxybenzoylecgonine: an important contributor to the immunoreactivity in assays for benzoylecgonine in meconium. J Anal Toxicol. 1993;17(6):348-352.
66. Konkol RJ, Murphey LJ, Ferriero DM, Dempsey DA, Olsen GD. Cocaine metabolites in the neonate: Potential for toxicity. J Child Neurol. 1994;9:242-248.
67. Lewis DE, Moore CM, Leikin JB, Koller A. Meconium analysis for cocaine: A validation study and comparison with paired urine analysis. J Anal Toxicol. 1995;19: 148-150.
68. Samperiz S, Millet V, Arditti J, et al. Value of toxicological research in newborn infants of addicted mothers by the study of several samples (urine, meconium, hair). Arch Pediatr. 1996;5:440-444.
69. Bibb KW, Stewart DL, Walker JR, Cook VD, Wagener RE. Drug screening in new-borns and mothers using meconium samples, paired urine samples, and interviews. J Perinat. 1995;15:199-202.
70. Ryan RM, Wagner CL, Schultz JM, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr. 1994;12:435-440.
71. Maynard E, Amoruso LP, Oh W. Meconium for drug testing. Amer J Dis Child. 1991;145:650-652.
72. Bandstra E, Steele B, Chitwood D. Detection of in utero cocaine exposure: A comparative methodologic study. Pediatr Res. 1992;31:58A.
73. Ostrea EM, Romero A. Selection criteria for routine drug screening of infants by meconium analysis. Pediatr Res. 1992;31:215A.
74. O'Connor TA, Bondurant HH, Siddiqui J. Targeted perinatal drug screening in a rural population. J Matern Fetal Med. 1997;6:108-110.
75. Ostrea EM, Lizardo E, Tanafranca M. The prevalence of illicit drug exposure in infants in the NICU as determined by meconium drug screen. Pediatr Res. 1992; 31:215A.
76. Yawn BP, Thompson LR, Lupo VR, Googins MK, Yawn RA. Prenatal drug use in Minneapolis-St. Paul, Minn. A 4-year trend. Arch Fam Med. 1994;3(6):520-527.
77. Ostrea EM, Knapp DK, Ostrea AR, Tannenbaum L, Saleri V. A prospective study comparing systematic interview and analysis of maternal hair and meconium to determine illicit drug use during pregnancy. Pediatr Res. 1994;34.
78. Ostrea EM, Knapp DK, Tannenbaum L, et al. Estimates of illicit drug use during pregnancy by comprehensive maternal interview, maternal hair analysis and meconium analysis: A comparative, prospective study. J Pediatr. (in press).
79. Ostrea EM, Romero A, Knapp DK, Ostrea AR, Utarnachitt RB. Postmortem analysis of meconium in early gestation human fetuses exposed to cocaine: Clinical implications. J Pediatr. 1994;124:477-479.
80. Morales V, Knapp DK, Utarnachitt R, Utarnachitt D, Ostrea EM. Meconium analysis will detect intrapartum drug use: Clinical implications. Pediatr Res. 1994;35.
81. Ostrea EM, Knapp DK, Romero A, Montes M, Ostrea AR. Meconium analysis to assess fetal exposure to active and passive maternal smoking. J Pediatr. 1994;124:471-476.
82. Mac E, Pacis M, Garcia G, Ostrea EM. A marker of fetal exposure to alcohol by meconium analysis. Pediatr Res. 1994;35.
83. Matias O, Keane C, Mac E, Utarnachitt R, Ostrea A, Ostrea EM, Mazhar M. Spectrum of drug exposure during gestation in neonates. Pediatr Res. 1995;35:264A.
84. Alano M, Ngoumgna E, Ostrea EM, Konduri G. Meconium analysis of nonsteroidal anti-inflammatory drugs and its relationship to persistent pulmonary hypertension of the newborn. Pediatrics, (in press).
85. Villanueva M, Svinarich D, Gonick B, Ostrea EM. Detection of cytomegalovirus in meconium using polymerase chain reaction. Pediatr Res. 1996;39:303A.
86. Ostrea EM, Tan E, Hernandez E, Ramirez GB, Manlapaz M. Exposure to environmental pollutants adversely affects fetal outcome. Pediatr Res. 1998;43:224A.